SCHEMBL3695604

SCHEMBL3695604

CC(C)(O)CN1CCN(C(=O)c2ccccc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.58
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
KDM4E B2RXH2 3/20 0.57
ALDH1A1 P00352 3/20 0.57
KCNH2 Q12809 1/20 0.57
FASN P49327 1/20 0.55
TDP1 Q9NUW8 1/20 0.54
LMNA P02545 2/20 0.54
SIGMAR1 Q99720 1/20 0.54
KCNA5 P22460 1/20 0.54
DRD2 P14416 1/20 0.54
HTR2A P28223 1/20 0.54
MAPK1 P28482 1/20 0.54
RAB9A P51151 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14595353 0.89 BLM (0.59) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL2156175 0.85 MEN1 (0.45) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL10293591 0.83 MEN1 (0.59) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL4293002 0.80 BLM (0.70) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL252026 0.79 HPGD (0.79) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL7129676 0.79 HPGD (0.79) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL10293583 0.78 MEN1 (0.66) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL3688168 0.78 MEN1 (0.64) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL10727700 0.78 KMT2A (0.69) BLMMEN1KMT2AKDM4EALDH1A1
SCHEMBL28135954 0.78 MEN1 (0.64) BLMMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2452939-B1 PIPERAZINYL 3-AMINOPYRROLIDINE DERIVATIVES AS A CCR2 ANTAGONIST YANG JI CHEMICAL CO LTD (KR) 2014-03-26 EP disclosed
US-8575173-B2 Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonists YANG JI CHEMICAL CO., LTD. (KR) 2013-11-05 US disclosed
US-8575173-B2 Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonists YANG JI CHEMICAL CO., LTD. (KR) 2013-11-05 US disclosed
US-8575173-B2 Piperazinyl 3-aminopyrrolidine derivatives as a CCR2 antagonists YANG JI CHEMICAL CO., LTD. (KR) 2013-11-05 US disclosed
US-20120190689-A1 PIPERAZINYL 3-AMINOPYRROLIDINE DERIVATIVES AS A CCR2 ANTAGONIST YANG JI CHEMICAL CO., LTD. (KR) 2012-07-26 US disclosed
US-20120190689-A1 PIPERAZINYL 3-AMINOPYRROLIDINE DERIVATIVES AS A CCR2 ANTAGONIST YANG JI CHEMICAL CO., LTD. (KR) 2012-07-26 US disclosed
US-20120190689-A1 PIPERAZINYL 3-AMINOPYRROLIDINE DERIVATIVES AS A CCR2 ANTAGONIST YANG JI CHEMICAL CO., LTD. (KR) 2012-07-26 US disclosed
EP-2452939-A2 PIPERAZINYL 3-AMINOPYRROLIDINE DERIVATIVES AS A CCR2 ANTAGONIST Yang Ji Chemical Co., Ltd. (KR) 2012-05-16 EP disclosed
WO-2011004972-A2 PIPERAZINYL 3-AMINOPYRROLIDINE DERIVATIVES AS A CCR2 ANTAGONIST 양지화학 주식회사 (KR) 2011-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190689-A1 PIPERAZINYL 3-AMINOPYRROLIDINE DERIVATIVES AS A CCR2 ANTAGONIST CCR2, CCR1, CCR9 BLM 3891/4885MEN1 3798/4885KMT2A 1789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.